Jean-Daniel Gerber, chairman of the board at SIFEM, explains why job creation should be the focus of DFIs (Development Finance Institutions) such as SIFEM; how ESG, environmental, social and governance issues, are key to a successful investment, and why we should focus on illnesses that are most prevalent in the developing countries, where the purchasing power is small and pharmaceutical companies lack strong incentives to invest.
Can you start by introducing yourself to our readers? You have had a career working for various parts of the Swiss government. What was it that attracted you to SIFEM?
Job creation should be the number one priority. SIFEM, just like other DFIs, has understood this
